NCT02804022View on ClinicalTrials.gov

Vital-signs-integrated Patient-assisted Intravenous Opioid Analgesia

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

December 29, 2016

Primary Completion Date

May 30, 2017

Study Completion Date

December 31, 2025

Conditions
Respiratory Depression
Interventions
DEVICE

VPIA analgesia

Recruited subjects will be given a VPIA device containing 1mcg/ml of morphine. Morphine will be administered via an intravenous infusion line with an anti-reflux valve to ensure precise drug administration and no backflow.

DRUG

Morphine

Recruited subjects will be given a VPIA device containing 1mcg/ml of morphine. Morphine will be administered via an intravenous infusion line.

Trial Locations (1)

229899

KK Women's and Children's Hospital, Singapore

All Listed Sponsors
lead

KK Women's and Children's Hospital

OTHER_GOV